Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing xenon-133 (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Xenon-133 (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Xenon[133Xe] 74-185MBq/mL in saline injection cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xenon-133 (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Xenon[133Xe] 74-1480MBq/mL gas cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xenon-133 (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Xenon[133Xe] 925-7400MBq/mL gas in multidose container |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xenon-133 (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Xenon[133Xe] 925-5550MBq/mL gas ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xenon-133 (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Xenon[133Xe] 60-2480MBq/mL gas vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xenon-133 (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Xenon[133Xe] 555MBq/mL in saline injection cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xenon-133 (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Xenon-133-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Xenon-133 (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing xenon-133 in respiratory dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xenon-133 (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Xenon-133 ventilation study |
Using substance (attribute) |
True |
Xenon-133 (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing xenon-133 in pulmonary dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Xenon-133 (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only xenon-133 (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Xenon-133 (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only xenon-133 in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Xenon-133 (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Xenon-133 only product in pulmonary dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Xenon-133 (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |